Dr. Salem is a Senior Clinical Lecturer (equivenent rank in US is associate professor) in Lung Cancer Research at the University of Manchester and Consultant in Clinical Oncology at The Christie NHS Foundation Trust, UK.
Clinically specializing in lung cancer radiotherapy, Dr. Salem’s research focuses on proton radiotherapy and the MR Linac, novel trials, biomarkers and hypoxia.
Dr. Salem has completed training in radiation oncology at King Hussein Cancer Centre (Amman, Jordan) in 2014, attaining fellowships and specialty certifications in clinical (FRCR), radiation (ESTRO fellowship & Jordanian board) and medical oncology (MRCP medical oncology & ESMO certification). Dr. Salem also completed a CRUK/EPSRC funded clinical research fellowship in 2017, attaining a PhD in Medicine from the University of Manchester for research focusing on non-invasive therapeutic lung cancer biomarkers.
Dr. Salem has successfully delivered several world-class clinical/ translational studies in lung cancer patients, publishing more than 56 peer-reviewed papers and many abstracts, posters and proceedings in eminent oncology conferences. Dr. Salem is a recipient of more than 10 prestigious academic oncology awards such as the ESTRO Accuray Award and the ASTRO International-US annual meeting scientific abstract award.
Apart from research, Dr. Salem is a keen educationalist. He is the current director of ESTRO FALCON lung cancer contouring workshops and supervisors a number of MSc and PhD students.
Dr. Salem’s career goal is to lead an innovative lung cancer advanced radiotherapy research portfolio, aiming to deliver survival and quality-of-life improvements for lung cancer patients.